CAS: 1803274-65-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BAY-1436032 REF: AN-AG00AMHDCAS: 1803274-65-8 | ≥98% | To inquire | Mon 13 May 24 |
 | BAY-1436032 REF: TM-TQ0042CAS: 1803274-65-8 | 99.65% | To inquire | Tue 21 May 24 |
 | BAY-1436032 REF: 3D-DXC27465CAS: 1803274-65-8 | Min. 95% | To inquire | Tue 25 Jun 24 |
Ref: AN-AG00AMHD
| 1mg | 105.00 € | |
| 5mg | 147.00 € | |
| 10mg | 241.00 € | |
| 25mg | 520.00 € | |
| 50mg | To inquire |
Estimated delivery in United States, on Monday 13 May 2024
BAY-1436032
CAS:1803274-65-8
BAY-1436032 is a novel, selective and orally available inhibitor of pan-mutant isocitrate dehydrogenase 1 (IDH1).
Formula:
C26H30F3N3O3
Purity:
99.65%
Color and Shape:
Solid
Molecular weight:
489.53
Ref: TM-TQ0042
| 1mg | 37.00 € | |
| 5mg | 78.00 € | |
| 10mg | 118.00 € | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 1ml*10 (DMSO) | 83.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
BAY-1436032
CAS:1803274-65-8
BAY-1436032 is a novel small molecule inhibitor of CXCR4. It has been shown to be …
Formula:
C26H30F3N3O3
Purity:
Min. 95%
Molecular weight:
489.53 g/mol
Ref: 3D-DXC27465
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 25 Jun 2024
